According to a recent industry analysis presented by Graphical Research, the Asia Pacific in Vitro Diagnostics (IVD) market is anticipated to enter the billion-dollar club in less than seven years, generating revenues of over 23.7 billion dollars by 2027. Molecular diagnostic tests are mainly used to analyze a patient’s DNA and RNA sequences and find their links to certain diseases. These tests play a crucial role in detecting infectious diseases well in advance to improve healthcare delivery. The COVID-19 pandemic further helped businesses promote the idea of fingerprint-based drug testing, which has also significantly impacted the market. Since the virus’s evolution rate is high, fingerprint-based drug testing can reduce the spread of the disease as it is non-invasive and hygienic, thereby increasing the use of IVD kits.
The development of IVD devices and solutions aims to provide faster, smaller, and more cost-effective tools that enable more precise diagnoses and point-of-care testing or self-testing. This edition of Med Tech Outlook APAC features the “Top 10 In Vitro Diagnostic Solutions Providers in APAC 2022,” throwing light onto some of the key developments in the space and how companies are leveraging IVD solutions to boost their growth.
The magazine highlights companies like Hangzhou AllTest Biotech Co., Ltd and its ever-growing capabilities to develop new types of products in order to keep pace with the global IVD industry. Additionally, this edition of MedTech Outlook APAC projects companies such as Thalys Medical Technology Group Corporation, a leader in integrated solutions for medical supply chain management, and its valuable insights on developing innovative and smart IVD devices.
The edition features thought leadership articles from CXOs the likes of Dr. Alastair Mah, Vice President of Medical Affairs, Jason Xing, Vice President of Information Technology, United Family Healthcare, and Jorge Silveira, Chief Digital Health Officer of global fertility services provider Virtus Health, who have imparted their opinions on how IVD can be developed to provide patients a head start while commencing their medical treatments with the help of an accurate diagnosis.
Please write to us about how you are leveraging In Vitro Diagnostic solutions in your organization.
